ArticleMolecular cancer2019

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Yu Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.